Pfizer teams up with digital therapeutics partner for next product launch, this time in atopic dermatitis
Big Pharma has been slowly but surely warming up to the potential of digital therapeutics, as evidenced by Sanofi inking a deal two months ago with DarioHealth. And on Thursday, another Big Pharma will take a look at the space in what it deems as simply the next step in an ongoing partnership.
Icelandic biotech Sidekick Health announced the launch of its digital therapeutics product specifically geared for atopic dermatitis Thursday alongside Pfizer, its Big Pharma partner who collaborated on the indication. CMO and co-founder Saemundur “Sam” Oddsson told Endpoints News that this is not the first time that Pfizer and Sidekick Health have worked together — in fact, it is the fourth digital therapeutics product that the pair have co-launched.
Keep reading Endpoints with a free subscription
Unlock this story instantly and join 144,300+ biopharma pros reading Endpoints daily — and it's free.